We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Prefers Automated Visual Inspection for Particulates in Injectables
FDA Prefers Automated Visual Inspection for Particulates in Injectables
The FDA offered advice on designing a visual inspection program to ensure injectable drugs are free of visible particulates in a new draft guidance released yesterday, noting that automated inspections may be more reliable than visual inspections by humans.